跳至主要内容
临床试验/ACTRN12618001958279
ACTRN12618001958279尚未招募2 期

Defining the Novel Effects of Mineralocorticoid Receptor Antagonism on Metabolism in Humans – A Randomised Controlled Trial

Dr Moe Thuzar0 个研究点目标入组 32 人开始时间: 2018年12月4日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • BMI 25-40 kg/m2

排除标准

  • (i) estimated glomerular filtration rate (eGFR) less than 60 ml/min
  • (ii) serum potassium more than 5mmol/L in a non-haemolysed blood sample
  • (iii) thyroid or endocrine dysfunction
  • (iv) significant organ dysfunction such as heart failure, liver failure
  • (v) active malignancy
  • (vi) pregnant or planning pregnancy
  • (vii) unable to provide informed consent
  • (viii) alcohol intake >14 standard drinks per week or smoking
  • (ix) Unable to maintain stable diet and lifestyle during the study period
  • (x) taking medications that may interact with spironolactone or have effect on metabolism such as anti-hypertensives acting on the renin-angiotensin or sympathetic system, diuretics, anti-diabetic medications, corticosteroids, anti-psychotics

研究者

发起方
Dr Moe Thuzar

相似试验